Antibody tests for identification of current and past infection with SARS‐CoV‐2
Background The diagnostic challenges associated with the COVID‐19 pandemic resulted in
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …
Diagnosis for COVID-19: current status and future prospects
ABSTRACT Introduction: Coronavirus disease 2019 (COVID-19), a respiratory illness
caused by novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), had its …
caused by novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), had its …
Evaluation of 11 SARS-CoV-2 antibody tests by using samples from patients with defined IgG antibody titers
N Lagerqvist, KT Maleki, J Verner-Carlsson… - Scientific reports, 2021 - nature.com
We evaluated the performance of 11 SARS-CoV-2 antibody tests using a reference set of
heat-inactivated samples from 278 unexposed persons and 258 COVID-19 patients, some of …
heat-inactivated samples from 278 unexposed persons and 258 COVID-19 patients, some of …
Plant molecular farming as a strategy against COVID-19–the Italian perspective
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has killed more than
37,000 people in Italy and has caused widespread socioeconomic disruption. Urgent …
37,000 people in Italy and has caused widespread socioeconomic disruption. Urgent …
[HTML][HTML] Detection of SARS-CoV-2 antibodies in serum and dried blood spot samples of vaccinated individuals using a sensitive homogeneous proximity extension …
H Zhao, M Wang, P Muthelo, L Löf, F Sterky, R Gallini… - New biotechnology, 2022 - Elsevier
A homogeneous PCR-based assay for sensitive and specific detection of antibodies in
serum or dried blood spots (DBS) is presented and the method is used to monitor individuals …
serum or dried blood spots (DBS) is presented and the method is used to monitor individuals …
Seroprevalence of SARS-CoV-2 in Sweden, April 26 to May 9, 2021
J Beser, I Galanis, T Enkirch, S Kühlmann Berenzon… - Scientific Reports, 2022 - nature.com
A national point seroprevalence study of SARS-CoV-2 was conducted in Sweden in April–
May 2021. In total, 2860 individuals 3 to 90 years old from a probability-based web panel …
May 2021. In total, 2860 individuals 3 to 90 years old from a probability-based web panel …
[HTML][HTML] Fluvastatin mitigates SARS-CoV-2 infection in human lung cells
FJ Zapatero-Belinchón, R Moeller, L Lasswitz… - Iscience, 2021 - cell.com
Clinical data of patients suffering from COVID-19 indicates that statin therapy, used to treat
hypercholesterolemia, is associated with a better disease outcome. Whether statins directly …
hypercholesterolemia, is associated with a better disease outcome. Whether statins directly …
Plant production of recombinant antigens containing the receptor binding domain (RBD) of two SARS-CoV-2 variants
F Fagiani, R Frigerio, AM Salzano, A Scaloni… - Biotechnology …, 2024 - Springer
Objectives The aim of this work was to rapidly produce in plats two recombinant antigens
(RBDw-Fc and RBDo-Fc) containing the receptor binding domain (RBD) of the spike (S) …
(RBDw-Fc and RBDo-Fc) containing the receptor binding domain (RBD) of the spike (S) …
[PDF][PDF] Fluvastatin mitigates SARS-CoV-2 infection in human lung cells
J Francisco, R Moeller, L Lasswitz, AK Overby… - researchgate.net
Clinical data of patients suffering from COVID-19 indicates that statin therapy, used to treat
hypercholesterolemia, is associated with a better disease outcome. Whether statins directly …
hypercholesterolemia, is associated with a better disease outcome. Whether statins directly …
[HTML][HTML] Evaluation of Eleven SARS-CoV-2 Antibody Tests by using Samples from Patients with Defined IgG Antibody Titers
N Lagerqvist, K Maleki, J Verner-Carlsson, M Olausson… - 2021 - europepmc.org
We evaluated the performance of eleven SARS-CoV-2 antibody tests using a reference set
of heat-inactivated samples from 278 unexposed persons and 258 COVID-19 patients, some …
of heat-inactivated samples from 278 unexposed persons and 258 COVID-19 patients, some …